Advertisement
Canada markets open in 8 hours 12 minutes
  • S&P/TSX

    21,714.54
    -297.08 (-1.35%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CAD/USD

    0.7258
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    81.17
    -0.76 (-0.93%)
     
  • Bitcoin CAD

    82,816.10
    -4,530.13 (-5.19%)
     
  • CMC Crypto 200

    1,290.41
    -48.66 (-3.63%)
     
  • GOLD FUTURES

    2,295.80
    -7.10 (-0.31%)
     
  • RUSSELL 2000

    1,973.91
    -42.12 (-2.09%)
     
  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     
  • NASDAQ futures

    17,526.50
    -44.75 (-0.25%)
     
  • VOLATILITY

    15.65
    +0.98 (+6.68%)
     
  • FTSE

    8,144.13
    -2.90 (-0.04%)
     
  • NIKKEI 225

    38,353.58
    -52.08 (-0.14%)
     
  • CAD/EUR

    0.6807
    +0.0005 (+0.07%)
     

Chemours (CC) Just Reclaimed the 50-Day Moving Average

From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 50-day moving average, and this suggests a short-term bullish trend.

One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of an up or down trend.

CC could be on the verge of another rally after moving 42.4% higher over the last four weeks. Plus, the company is currently a Zacks Rank #2 (Buy) stock.

Once investors consider CC's positive earnings estimate revisions, the bullish case only solidifies. No estimate has gone lower in the past two months for the current fiscal year, compared to 1 higher, and the consensus estimate has increased as well.

ADVERTISEMENT

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on CC for more gains in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Chemours Company (CC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research